Sergio Cifuentes Canaval

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Sergio Cifuentes Canaval
Jun 28, 2025, 14:17 | Blog
Sergio Cifuentes Canaval: Congratulations to the winners of the "ACHO Defying Cancer" Program for Conquer Cancer, the ASCO Foundation
Sergio Cifuentes Canaval, ASCO International Development and Education Award (IDEA) Recipient – 2025 at Conquer…
Jun 28, 2025, 06:28 | Blog
Sergio Cifuentes Canaval: SERENA-6 - Unpacking the Economic Reality of ESR1m Surveillance in Breast Cancer
Sergio Cifuentes Canaval, ASCO International Development and Education Award (IDEA) Recipient – 2025 at Conquer…
Jun 12, 2025, 15:26 | Science
Sergio Cifuentes Canaval Shares Key Insights on Clinical Trial Barriers Related to Race and Older Age
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, shared a post on Linkedin:…
Jun 12, 2025, 09:57 | Blog
Sergio Cifuentes Canaval: Immuno-oncology in Breast Cancer - Progress, Gaps, and Research Opportunities
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, shared a post on LinkedIn:…
May 8, 2025, 14:15 | Blog
Sergio Cifuentes: Comparative Neoadjuvant and Adjuvant Studies in HER2-Positive Breast Cancer
Sergio Cifuentes, Cancer Research Project Manager at CENEIT México, posted on LinkedIn: "HER2-positive breast cancer…
Apr 25, 2025, 17:47 | Blog
Sergio Cifuentes Canaval: My abstract was accepted for online presentation at the 2025 ASCO Annual Meeting
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, posted on LinkedIn: “I’m pleased…
Apr 7, 2025, 08:34 | Blog
Sergio Cifuentes Canaval: Extended Reduced-Dose Apixaban for Cancer-Associated VTE
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, posted on X: "API-CAT Study:…
Apr 7, 2025, 08:29 | Blog
Sergio Cifuentes Canaval: Results of SBRT for Primary RCC in a Large Multicenter Series
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, posted on X: "Results of…
Apr 5, 2025, 18:53 | Science
Sergio Cifuentes Canaval: Selective sentinel node biopsy in people over 70 years of age
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, shared a post on LinkedIn…
Feb 28, 2025, 08:09 | Blog
Sergio Cifuentes Canaval: Treatment Beyond ADCs Progression and ADCs Sequencing
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared a post on LinkedIn:…
Nov 8, 2024, 19:01 | Insight
Predictors of Response to CDK4/6i Rechallenge in ER+ Metastatic Breast Cancer
Sergio Cifuentes Canaval, Medical Oncology Fellow at National Autonomous University of Mexico, shared a post…
Nov 8, 2024, 16:10 | Blog
Sergio Cifuentes Canaval: Predictors of Response to CDK4/6i Rechallenge in ER+ Metastatic Breast Cancer
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, posted on LinkedIn: "Predictors of…
Sep 30, 2024, 15:49 | Blog
Sergio Cifuentes Canaval: Excited to be participating in the Empower GI Symposium at the University of Alcalá!
Sergio Cifuentes Canaval, Student Fellow at National Autonomous University of Mexico, shared on LinkedIn: "Excited…
Sep 22, 2024, 09:21 | Blog
Sergio Cifuentes Canaval about his experience oncology rotation abroad in Spain
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared on LinkedIn: "Hello everyone!…
Aug 8, 2024, 10:01 | Blog
Sergio Cifuentes Canaval: How NACT compares to adjuvant chemotherapy for patients with HR+/HER2− breast cancer
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared on LinkedIn about recent…
Aug 2, 2024, 02:02 | Blog
Sergio Cifuentes Canaval: Impact of CDK4/6 Inhibitors on Brain Metastases in HR+/HER2- Metastatic Breast Cancer
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared on LinkedIn about recent…
Aug 2, 2024, 01:47 | Blog
Sergio Cifuentes Canaval: Neoadjuvant Chemo-Immuno for ER+ HER- breast cancer
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared on LinkedIn about recent…
Jul 21, 2024, 20:01 | Insight
Optimal Anastrozole Dose for Estrogen Suppression in Postmenopausal Breast Cancer
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, shared on LinkedIn a recent…
Jul 6, 2024, 11:56 | Insight
The NETTER-2 phase 3 trial has provided groundbreaking data on GEP-NETs
Ulum App, shared a post by Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico,…
Jul 2, 2024, 02:01 | Blog
Sergio Cifuentes Canaval: Exciting Advances in Immunotherapy for Colon Cancer
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared on LinkedIn: “Exciting Advances…
May 19, 2024, 14:53 | Insight
Sergio Cifuentes Canaval: KN 189 and 407 - Pooled Analysis of Outcomes
Sergio Cifuentes Canaval, Student Fellow at National Autonomous University of Mexico, shared on LinkedIn: "KN 189…
May 15, 2024, 13:45 | Blog
Sergio Cifuentes Canaval: Exciting insights from the MRI-guided optimization study in HER2+ breast cancer!
Sergio Cifuentes Canaval, Student Fellow at National Autonomous University of Mexico, shared a post on LinkedIn:…
May 9, 2024, 09:54 | Insight
Sergio Cifuentes Canaval: My takeaways from new analysis of the CheckMate 9ER trial
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, shared on LinkedIn: "Nivolumab + Cabozantinib: Numbers…
Apr 19, 2024, 06:30 | Insight
Summary of KEYNOTE-A18 by Sergio Cifuentes Canaval
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, shared on X/Twitter: "KEYNOTE-A18: Pembrolizumab…
Apr 19, 2024, 06:19 | Insight
Sergio Cifuentes Canaval: I'm thrilled to share groundbreaking progress in the treatment of locally advanced cervical cancer (LACC)!
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, shared on LinkedIn: "I'm thrilled to…
Apr 14, 2024, 22:26 | Insight
Sergio Cifuentes Canaval: Wu Y-L et al. have just released the results of a preplanned interim analysis from the ALINA trial
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, shared a post on LinkedIn:…
All: 26 Posts: 1 - 100
Special Coverage